DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

STEMCELLS, INC.

NASDAQ: STEM

1.83 -0.05 (-2.66%)

Quote as of

company name or ticker

Recent Quotes

STEM $1.83 -2.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.90
Previous Close $1.88
Daily Range $1.82 - $1.90
52-Week Range $0.59 - $2.67
Market Cap $71.3M
P/E Ratio -2.65
Dividend (Yield) $0.00 (0.0%)
Volume 358,804
Average Daily Volume 354,789
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company

Investing In The Stem Cell Sector: An Overview

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy

StemCells Management Discusses Q4 2012 Results - Earnings Call Transcript

Phase II Trials Will Be Pivotal For These Stem Cell Companies

4 Biotech Stocks Under $5 to Watch

Geron Earnings: An Early Look

Let's look forward to this company's next earnings report.

StemCells' Recent Share Price Drop

See More STEM News...

STEM's Top Competitors

STEM $1.83 (-2.66%)
Current stock: STEM
AMGN $105.91 (0.27%)
Current stock: AMGN
GILD $55.81 (0.59%)
Current stock: GILD
BIIB $235.24 (1.13%)
Current stock: BIIB